Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Saffran asks Supremes to hear appeal against J&J’s Cordis
Stent pioneer Dr. Bruce Saffran wants the U.S. Supreme Court to hear an appeal of a lower court’s decision to overturn his $600 million patent infringement win over Johnson & Johnson’s Cordis stent-making arm.
2. Government shutdown: What of FDA’s October meetings?
The FDA is still planning on holding this week’s medical device review advisory panels but other meetings have been shut down as the agency is forced to furlough 45% of its workers and halt all user fee collections.
1. Is renal denervation over-hyped?
Many of the medtech industry’s biggest players have put large stakes in renal denervation as a new device-based option for patients with drug-resistant hypertension, but the global barriers to adoption may be taking some of the shine off this much-hyped market.
